Bioanalytical Systems - Comparative Multiple Analysis

Bioanalytical Systems (Comparative Multiple Analysis)


Notes on the Comparative Multiple Analysis of Bioanalytical Systems

WikiWealth compares Bioanalytical Systems's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Bioanalytical Systems's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Bioanalytical Systems.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Bioanalytical Systems's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Bioanalytical Systems's Analysis

How does this work? The Comparative Investment Analysis determines the value of Bioanalytical Systems by comparing Bioanalytical Systems financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Bioanalytical Systems.

See the Bioanalytical Systems cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Bioanalytical Systems.

Also, see the Bioanalytical Systems's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Bioanalytical Systems's valuation conclusion for a quick summary.